New Data from Immunotherapy Quality of Life Study Accepted for Two Abstracts at 2023 ASCO

— Treatment Technologies & Insights’ (TTI) ePRO app solution, Wave Health, enabled innovative approach to capture real-world symptoms and side effects —

SEATTLE, WA and EL SEGUNDO, CA, May 31, 2023 – The Wave Health digital health platform, used to collect patient symptom and quality of life information in an innovative research study, comprises two abstracts accepted to the 2023 ASCO Annual Meeting. The study used TTI’s electronic patient reported outcomes (ePRO) platform to measure a variety of symptoms and aspects of health-related quality of life (HRQoL) in the “ImmunoWave” study, conducted at Fred Hutchinson Cancer Center. 

Dr. Hall, Assistant Professor at Fred Hutchinson Cancer Center and University of Washington School of Medicine, who led the study said, “Immune checkpoint inhibitors (ICI) have transformed the care of many cancers and are among the most commonly prescribed cancer medications in the United States. Relatively little is known about the symptom and life experience of patients who have received this type of treatment in the past. The use of a patient-friendly ePRO system in this study enabled us to frequently and conveniently assess symptoms and quality of life in a group of patients who are not frequently coming in for infusions and visits.”

The study assessed for the presence of eleven symptoms and overall quality of life in a group of participants with prior exposure to ICI therapy or ongoing long-term ICI treatment. Participants in the study completed weekly symptom and HRQoL assessments using Wave Health. The two abstracts submitted to the 2023 ASCO Annual Meeting include:

Study participants completed the majority of the assessments, providing crucial evidence of the feasibility of this technology to measure symptoms and HRQoL in this population. Participants reported frequent, persistent, and often severe symptoms, most notably fatigue, mental health symptoms and musculoskeletal symptoms. The study also identified which symptoms appeared to correlate most with diminished quality of life. For example, symptoms of depression, joint pains, and shortness of breath were associated with decreased physical functions on HRQoL measures.

“This study demonstrated that ePRO assessment is feasible in the population of cancer patients who are receiving or have completed ICI therapy. We have been able to collect much richer data using this approach than if we had relied on patients completing pen-and-paper questionnaires when they presented for clinic visits. This study lays the groundwork for future important studies of patient experience during and after ICI treatment,” said Dr. Hall.

TTI CEO and Wave Health creator, Matt Lashey, added: “These early learnings have already informed multiple new projects underway in Europe centered on both early and later stage cancer patients. In addition to the app, we now have a connected ePRO portal, Wave Health Connect, to elevate shared decision making and drive the ability to triage emerging adverse events.”

For the “ImmunoWave” study, in addition to weekly ePRO monitoring resulting in high questionnaire completion rates, study participant feedback on the Wave Health app tool was very positive.  Specifically, of those patients who completed the study off-boarding survey: 90% said they would “recommend the app to a friend going through similar circumstances;” and 80% said using the Wave Health app “helped them understand better how to live with their condition.”  Correspondingly, less than 5% of participants who completed the study off-boarding questionnaire, did not find the app “easy to use.” 

Treatment Technologies & Insights/Wave Health

TTI is a digital health insights and real world data (RWD) company, powered by the best-in-class electronic patient reported outcome (ePRO) ecosystem, Wave Health.  Born from a personal cancer experience, Wave Health transforms the understanding and management of chronic conditions – outside the clinical setting.  Wave Health App empowers patients to become more active partners with their care teams by helping them track and communicate their symptoms and experiences; the Wave Connect PRO Portal enables care teams to digitally augment care, with a lens into the patient journey at home; and Wave Health RWD supplements clinical data with critical context and individual variables.

Wave Health’s Alex Whitehead Featured on Asembia 2022 Conference Panel

Editor’s Note: CoverMyMeds is publishing recaps of Monday, Tuesday and Wednesday Asembia 2022 sessions

Over 6,000 attendees are gathered this week in Las Vegas for Asembia 2022, a specialty pharmacy summit. We attended Wednesday’s sessions, which were focused on incoming tools and trends specialty pharmacists can use to help patients get the medications they need — from more affordable and available biosimilars to equitable adherence strategies.

Session: “Pharmacist Evolution: A New, More Active Role from Patient-Reported Outcomes to Developing Insights”

Presenters: Alexandra Broadus, senior director, Specialty Health Solutions, Walgreens; Melanie Radi, manager, Clinical Programs, AllianceRx Walgreens Prime; Alex Whitehead, senior director, strategy and partnerships, Treatment Technologies & Insights (TTI); Jeff Bourret, senior director, North America Medical Affairs, Inflammation & Immunology, Pfizer

Patient-reported outcomes data is essential for individualized care — full stop.ALEX WHITEHEADSenior Director, Strategy and Partnerships, Treatment Technologies & Insights (TTI)

Summary: What was discussed

Patient reported outcomes (PRO) are anything a patient directly says that’s not influenced by a clinician or other care team member. With the push to collect more real-world data, accelerated by the introduction of the 21st Century Cures Act in 2016, the industry is looking to PRO to influence public health and individualized care plans.

However, the individualization of PRO makes collecting and standardizing this data tricky. This panel of pharmacy experts examined ways specialty pharmacy can use PROs to address shifting adherence and outcomes barriers on an individual level.

Alex Whitehead, senior director of strategy and partnerships for Treatment Technologies & Insights, discussed a specialty pharmacy app that allowed patients to self-report daily symptoms, side effects and generally how they were feeling as they initiated a new medication. The app then reflected trends to the patient that could indicate triggers for symptoms. It also deep linked to educational information about symptom management. While patients are usually very active in the first week or two, they often fall off using it due to the strain of keeping up with multiple comorbidities or simply the business of life, said Melanie Radi, manager of clinical programs at AllianceRx Walgreens Prime. Such is the case for many self-reporting adherence applications.

That’s where integration with pharmacy workflows can help. Care team members could then step in when they see a patient having difficulties adhering to medications or experiencing unpleasant side effects. This can also provide an opportunity to connect with patients who may need an alternative communication method, such as a phone call where they can talk through challenges related to their condition or medication. Further benefit comes from specialty pharmacists having easy pathways to connect with care teams when they feel a drug may not be working or further clinical intervention is needed.

Key takeaways: What’s most important

Whitehead said it best. “Patient-reported outcomes data is essential for individualized care — full stop,” he said. While social determinants of health and symptom data gathering are important, taking individualized action for the patient at hand is most important to driving positive outcomes and keeping costs down for all stakeholders.

“Information gathered based on patients’ everyday behaviors might lead to different actions for different care plans,” Whitehead said. “They may be able to ask how many minutes a day someone’s doing yoga, are they praying if they’re religious or keeping in touch with their mother, for example.” Panelists emphasized the continued need for information and interventions to be offered in mediums beyond digital. Paper educational materials in multiple languages, phone calls and even locating care team members in pharmacy deserts could help access greater sets of patients who may often be forgotten or left behind, said Jeff Bourret, senior director of North America Medical Affairs, inflammation and immunology at Pfizer.

Industry call to action

Many patients want to be an active participant in their care. The industry can and should look for opportunities to partner with the patient throughout their care for an improved experience, outcomes and better adherence. Biopharma companies are often specialty pharmacy’s closest partners in developing PRO solutions, helping to define the patient journey to co-create an experience for the patient.

Specialty pharmacies who are willing to partner in creating solutions to gather and act on patient data can further let providers know what they’re learning about the patient to improve their care.

Asembia 2022 – Pharmacists Have a New, Active Role in Patient-Reported Outcomes

May 4, 2022 Aislinn Antrim, Associate Editor – Pharmacy Times

Pharmacists can play a more active role in educating patients on tools and resources available to them, enrolling patients in programs, gathering subjective and objective data.

Pharmacists are increasingly playing an active role in the collection of patient-reported outcomes and the use of real-world evidence, according to a session at the Asembia 2022 Specialty Pharmacy Summit.

Real-world data are information related to patients’ health status or the delivery of health care, according to presenter Alexandra Broadus, PharmD, senior director of specialty health solutions at Walgreens. These data are routinely collected from a variety of sources and go hand-in-hand with real-world evidence, which is clinical evidence about the use and potential benefits or risks of a medical product derived from real-world data.

The importance of real-world data is reflected in policies and laws, including the 21st Century Cures Act that was signed into law in 2016. Designed to accelerate product development and get innovations to patients more quickly, the act uses real-world data and created a framework for evaluating the use of real-world evidence to support the approval of a new indication for a drug that has already been approved.

Patient-reported outcomes (PROs) are an important piece of real-world data, Broadus said. PROs are any report of the status of a patient’s health condition that comes directly from the patient. These outcomes can be measured in absolute terms, such as severity of a symptom, or as a change from a previous measure.

After introducing the role of PROs in clinical research and innovations, the panelists discussed some examples within their own organizations of how pharmacists are involved in gathering insights. Pharmacists can play a more active role in several ways, including by educating patients on tools and resources available to them, enrolling patients in programs, gathering subjective and objective data, and taking action in near real time based on PROs via digital solutions.

Alex Whitehead, senior director of strategy and operations at Treatment Technologies and Insights (TTI), discussed a partnership program between TTI and Walgreens to better engage, monitor, and improve outcomes for patients taking oral oncolytic medications. The technological piece of the partnership involves connecting a platform with artificial intelligence-driven patient apps and a corresponding pharmacist care portal.

Through this partnership, Whitehead said synthesized reports are available to health providers and pharmacists to summarize patients’ experiences. An app also allows patients to report things that make them feel better or worse on a day-to-day basis, better enabling providers to respond quickly to patient challenges.

Pharmacists’ roles in this program include offering it to patients at applicable touchpoints, reviewing patient engagement and reports before scheduled interactions with the patient, and conducting informed consults.

Panelist Melanie Radi, PharmD, manager of clinical programs and specialty clinical services at AllianceRx Walgreens Prime, further discussed pharmacists’ roles in collecting and interpreting PRO data. The Connected Care Program is a PRO algorithm-driven clinical program, and she noted that all PROs and counseling provided to patients are documented in the patient profile.

As part of the program, pharmacists will conduct an initial call with the patient to discuss personal information, an initial assessment, the prescription order, and the patient’s communication preferences. Refill calls are also conducted as proactive outreach, and cover adverse effects, potential adherence issues, and changes to the patient’s symptoms or condition.

All of the panelists agreed that including PROs in addition to more objective, clinical data points can have significant benefits. Importantly, Radi said PROs help to individualize care, which is vital in the patient journey and helps patients feel heard and understood.

“It empowers those patients, I think, to really take control of their care and to be an advocate for themselves, knowing they have the support of their specialty pharmacist as they go through this journey,” Radi said.


Broadus A, Radi M, Bourret J, Whitehead A. Pharmacist Evolution: Introducing a New, More Active Role from Patient Reported Outcomes to Developing Insights. May 4, 2022. Presented at Asembia 2022 Specialty Pharmacy Summit.

Health App That Tracks Response to Diseases Rated No. 1 by Cedars-Sinai Medical Center – Epoch Times

December 15, 2021 – By Drew Van Voorhis – Epoch Times

A unique health app that allows patients to track how treatments, medications, and diets affect different medical conditions using artificial intelligence was recently rated number one by Cedars-Sinai Medical Center in a study involving over 1,100 different health applications.

The app, called Wave Health, allows patients with illnesses including cancer, migraines, chronic pain, and about 250 other chronic illnesses to feel more in control over their disease by helping them discover what could make them feel better or worse on a daily basis.

Wave received the number one rating in both the highest overall score, but also the highest for individual scores for engagement and aesthetics dimensions.

“[Being rated number one] was validating for us, but in a very different way because we were born out of a personal experience that led to a personal mission to help patients,” Matt Lashey, cofounder of Wave Health, told The Epoch Times.

The app was created by Lashey and his partner Ric Grenell, former Acting Director of U.S. National Intelligence after Grenell was diagnosed with cancer in 2013.

“When you’re diagnosed with cancer, you think, ‘I’ve got cancer, so I’m going to feel crappy,’ Grenell told The Epoch Times. “And when you start to feel terrible, you chalk it up to the cancer and you don’t know any different.”

Grenell found that through analyzing his daily symptoms through data trends, he could pinpoint what medications were working, and what was not.

Grenell and Lashey created the app to help patients who are dealing with a negative health diagnosis navigate an overwhelming amount of information, and give insight into the crucial decisions that need to be made.

“There’s a whole bunch of apps out there that do symptom tracking, and then they just summarize the symptoms into a report,” Grenell said. “What [Wave Health] does … is it creates this system that then gives you artificial intelligence that takes your information and then gives you actionable insights.”

Wave Health allows a patient to put in a percentage scale of how they feel at any given moment and tracks sleep, condition changes, mood, hydration, exercise, social interaction, and meals. It also measures blood pressure, heart rate, and other vitals.

The app’s artificial intelligence then gives health reports and insights that show important trends for both the user and their doctors.

The app has a back-end monitoring platform that can allow physicians to monitor their patients in real-time.

“We’ve actually had a lot more attention from providers who are much more focused on telehealth solutions, or solutions that would help them to keep in better touch and a closer eye on their patients between visits, to help prevent emerging risks and the resulting hospitalizations,” Lashey said.

Wave Health has also been a game-changer during the pandemic, Grenell said, given that there has been a greater emphasis on providers protecting chronic patients from the risk of exposure in emergency room settings.

“If you’re chronically sick, and you start using this, the insights that are generated are going to motivate you to improve your own health,” Grenell said.

Grenell added that he’s excited to continue developing the app into different languages to help others around the world.


Health app monitors cancer symptoms and treatments in Hebrew and Arabic – The Jerusalem Post

The free Wave Health app is now available in nine languages.

December 13, 2021 – 20:44


Wave Health, a free mobile application by Treatment Technologies & Insights (TTI) that allows users to monitor their disease symptoms, treatments, medication side-effects and more, just became available in Hebrew and Arabic, founding partner Richard Grenell announced Sunday.With the latest addition, the app is currently available in nine languages.

Grenell started to conceive of the Wave Health project when he was diagnosed with non-Hodgkin’s lymphoma – a type of blood cancer – in 2013.

All of a sudden he found himself in a situation where he needed to handle a lot of medical information: his symptoms, the medications he needed to take, their side-effects, treatments and their side-effects and so on. Being able to keep track of all of this data – and when relevant, convey it to his physicians – could make a big difference in the success of the therapy.

The experience prompted Grenell to establish TTI. With the help of his partners, he was able to monitor the course of his disease and treatment, feel in control of what was happening and have a better dialogue with his doctors.

Inspired by his journey, in 2017 the company released chemoWave, an app for cancer patients and their families.Eventually, TTI released Wave Health, which focuses on supporting patients will chronic diseases.

Earlier this year, the app was rated the number-one highest-quality Health application to track patient-reported outcomes for oncology patients by the Cedars-Sinai Medical Center in Los Angeles.“

The COVID-19 pandemic has introduced significant challenges in ensuring oncology patients understand their symptoms and receive the best possible care,” said Matt Lashey, TTI CEO and the creator of Wave App. “We take great pride in empowering patients to take an active role in their treatment and to effectively communicate with their care teams, especially in a remote world.”

For the future, the company is working on creating several apps tailored for specific diseases and treatments, including diabetes, kidney problems, dialysis, fertility treatments and others.


Health App Tracks Disease Symptoms, Medications, Side Effects, More – Newsmax Health

Health App Tracks Disease Symptoms, Medications, Side Effects, More

Friday, December 10, 2021 03:35 PM –

By: Lynn Allison

There’s an exciting health app that you can download for free that helps monitor your symptoms, keep track of medications, and identify side effects for a wide variety of medical conditions including cancer, chronic pain, migraines, and even anxiety and depression. Called Wave Health, it is available for both iPhone and Android devices. The mobile app was rated #1 by Cedars Sinai Hospital for tracking patient-reported outcomes, or PROs, for oncology patients.

Necessity is often called the mother of invention, and this certainly was the case for the development of the Wave Health app. When Ric Grenell, former acting director of national intelligence and former U.S. ambassador to Germany, battled non-Hodgkin’s lymphoma, he was thrown into a nightmare of chemotherapy and its accompanying side effects. Grenell’s partner, Matt Lashey, helped track Grenell’s symptoms and therapies so they could remember which treatments and medications made him feel better or worse. The couple used the data to accurately communicate this information to Grenell’s physicians.

Fortunately, Grenell’s cancer went into remission. Lashey, whose background is in market research and data analysis, designed an app for tracking treatments and symptoms and together they co-founded Treatment Technology & Insights (TTI), a Los Angeles-based company, to share their discovery with others. In the beginning, the app was dedicated to cancer treatments alone, but now includes over 250 diseases that can be monitored with a few taps on a smartphone and the help of artificial intelligence.

“My first dream is to empower patients, to give them hope and help them play a productive role in their care,” Lashey tells Newsmax, adding that he is now excited for its application in the future. “By analyzing the aggregate data, we can start to identify certain patient characteristics and trends that will impact innovation and the development of new treatments.”

The app also measures blood pressure, heart rate and other vitals, making it an all-in-one, comprehensive patient tracker, says Jaren Grenell, Ric’s nephew, and creative director of TTI. It also syncs with wearables.

‘We are global, and the app is available in virtually every country including the Middle East,” Jaren Grenell tells Newsmax. “We have just made it available in Arabic and Hebrew. There are not many tools available for patients to track their health while facing chronic illness and cancer.”

Another key feature of Wave Health is enhanced communication for patients. “We send users weekly health reports with a breakdown of important trends and data points,” says Grenell. “It’s sent to them weekly, but also has a 28-day trends report that many patients take to their doctors’ appointments to better understand what’s going on with symptoms and overall help.”

Grenell explains that a patient can share updates with their healthcare provider directly from the app or can update the service and subscribe to Wave Pro, which is a more comprehensive, report-generating version of the app available for a modest, monthly fee.

“We’re currently offering 30 days free, and you can cancel anytime,” says Grenell. To find out more about the Wave Health app, take a tour of their website.

For Rosalind Williams, a breast cancer patient in Seattle, the app helped her battle grueling chemotherapy, surgery, and radiation.  She told Newsmax that tracking her symptoms helps identify issues and communicate them with experts who know how to deal with them.

“Along with family and prayer, the app is helping me go through the process,” she said.


© 2021 NewsmaxHealth. All rights reserved.

Wave Health App Now Available In Arabic and Hebrew Languages

Free Patient Health App Now Available In Arabic And Hebrew Languages

-Wave Health Is Empowering Patients To Track And Record Their Treatment Experience In 175 Countries-

-Treatment Technologies & Insights, Inc. (TTI) Helps People Facing 240+ Chronic Medical Conditions Get Health Insights From Custom-built Artificial Intelligence Platform-

LOS ANGELES, CA (December 10, 2021) – Wave Health App, a mobile app rated #1 by Cedars Sinai Hospital, today launched its patient technology in Arabic and Hebrew languages. The free health app helps patients track their symptoms, log how they’re feeling, and record important treatment activities to get personal health insights into what helps them feel better or worse, and what activities are tied to negative side effects they experience.

The app is now launched throughout the Middle East and is currently available for free on all iPhone or Android devices in 175 countries. Wave Health has already been previously available in English, German, Spanish, and French, with plans to launch in other languages in the near future.

“We decided to develop the app in Arabic and Hebrew languages, which was a challenge, as it’s an entirely different layout from every other language we have released thus far. So, we consulted with a few doctors in Egypt during the translation phase to make sure we got it right,” says TTI’s Technical Lead, Armando Monroy.

In a recent systematic review out of Cedars-Sinai Medical Center (CSMC), Wave was rated as the #1 highest quality mHealth application to track patient-reported outcomes (PROs) for oncology patients.

Wave was updated in 2019 to serve more than cancer patients, as the health app is growing rapidly and reaching more people with complex medical conditions, such as Chronic Pain, Migraines, Ehlers Danlos, Fibromyalgia, Hypertension, and the most impactful growth has been in the Mental Health space, especially since the Covid-19 pandemic. Anxiety and Depression remain the fastest growing conditions over the past 18 months.

Wave has a growing and motivated patient community with several thousand active users across 240+ chronic conditions. Wave users log into the app, on average, 5.5 times per day to actively track their entire treatment experience, including updating their symptoms daily, while logging their mood, sleep, hydration, mindfulness, physical exercise, and much more.

Recent results from a user survey obtained on December 9, 2021, amongst 431 Wave users, showed that 94% of users reported that Wave has been a helpful aspect of their treatment journey. Amongst those users, more specifically, 80% reported they feel more “in control” of managing their symptoms.

Wave Health is a free mobile health app from Treatment Technologies & Insights (TTI), a digital health company that creates patient-centered mobile apps and develops physician portals and research platforms to help improve healthcare outcomes for cancer and chronic illness patients.

Wave App’s technology offers a holistic, real-time record & analysis of patient experiences, designed to engage patients in managing treatment side effects, provide doctors with better information for more confident decision-making, and ultimately improve health protocols that lead to better outcomes in the future.

TTI entered the Patient Reported Outcomes (PRO) space in 2017 through their launch of chemoWave, a free health app for cancer patients with the same insights and activity tracking capabilities as Wave App. chemoWave is also available across all iPhone or Android mobile platforms.

Read more about the personal story that led to the creation of chemoWave in the American Journal of Managed Care.

Download Wave App FREE for Android here

Download Wave App FREE for Apple iOS here

Follow us on Facebook and Twitter.

Contact:          Jaren Grenell

Treatment Technologies & Insights Launches Immunotherapy Study At Seattle Cancer Care Alliance

— Patient Reported Outcome pilot to examine the symptom experience of long-term Immunotherapy patients to better understand chronic effects of treatment —

— With drug approvals increasing every year, and clinical trials over-representing patients with better health and fewer comorbidities, critical pilot to examine real-world patient experiences —

LOS ANGELES, October 26, 2021 – Nearly half of all adult advanced-cancer patients are candidates for treatment with immune checkpoint inhibitors (ICIs).  Immunotherapy triggers the body’s immune system to fight cancer cells but can also precipitate a host of side effects ranging from mild to life threatening, driving a wide variety of symptoms that can adversely impact patient quality of life and day-to-day functioning.

Wave Health app, ranked the #1 rated PRO application for oncology patients in 2020 by Cedars-Sinai, today announced a pioneering new study to enable an innovative approach to monitor real-world immunotherapy symptoms and side effects that could shorten the cycle for patients and physicians to understand how it really feels to be on their medications.

“In the past 10 years, there have been approximately 40 new drug approvals every year. Unfortunately, there is often limited data on side effects, tolerability and quality of life at the time of approval,” said Treatment Technologies & Insights CEO Matt Lashey.  “TTI’s technology changes that by transforming reported data into actionable intelligence.”

TTI lead engineer Armando Monroy added: “The study’s app provides an AI-driven ePRO solution within the infrastructure of Wave Health’s current system.  Specifically, the technology allows SCCA participants, using either iPhone or Android versions of the app, to securely track and share profile information, symptom occurrences and other relevant activity and experience information – to generate personal insight for treatment understanding and ultimately care team management.” 

For the 3-month study, with a rolling enrollment of approximately 50 patients, app users complete symptom assessments using the National Cancer Institute’s “Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events” (PRO-CTCAE).  These instruments measure symptom toxicity in clinical trials and consist of 78 discrete symptoms.  The appasks subjects to report on a subset of these symptoms of specific interest to the SCCA study.

Additionally, TTI has implemented a new HRQoL weekly series of surveys using the PROMIS-29-item questionnaire to assess health-related quality of life across various domains of interest to the study. Monroy explains: “Subjects are asked additional PROMIS short form items as a follow up to the subset of PRO-CTCAEs they earlier reported as having experienced at a ‘moderate,’ ‘severe’ or ‘very severe’ level in the last 7 days.  This lays tremendous new groundwork for future interventional studies on adverse event prevention and management by demonstrating patient-level impact.”

Treatment Technologies & Insights, parent company of Wave Health, is a digital health company offering cloud-based services to systematically monitor, manage and learn from patient reported outcomes – occurring outside the clinical setting.  TTI’s mission is to transform healthcare by equipping every patient and healthcare ecosystem with life-changing patient intelligence. 

Through unique patient engagement and AI-driven insights, TTI’s patient-centric solutions, including apps, a provider-facing care portal, and research databases, help elevate patient health literacy, decrease population health disparities and create opportunity for intervention to benefit patients, caregivers, providers, payors, and pharmaceutical companies.  TTI started first in cancer, from a personal experience, and now serves all chronic conditions. 

Download Wave Health App FREE for Android here

Download Wave Health App FREE for iOS here

Follow Wave Health on Social:

Follow Treatment Technologies & Insights on Social:

SOURCE: Treatment Technologies & Insights, Inc.

Wave Health Rated #1 mHealth App By Cedars-Sinai Medical Center


Department of Radiation Oncology at Cedars-Sinai Medical Center conducts study in response to rapid growth in use of telehealth / telemedicine due to the COVID-19 pandemic.

LOS ANGELES, Jan. 14, 2021 /PRNewswire/ — Wave App, a free mobile application for more than 150 chronic conditions helping patients take greater control of their health during treatment, today announces that a systemic review out of Cedars-Sinai Medical Center (CSMC) rated Wave as the #1 highest quality mHealth application to track patient-reported outcomes (PROs) for oncology patients.

The Department of Radiation Oncology at CSMC conducted the study in response to the COVID-19 pandemic, which has highlighted the importance of remote symptom monitoring and patient-provider communication.

All PRO applications were evaluated using the mobile apps rating scale (MARS), which scores across app engagement, functionality, aestheticsinformation, and subjective quality. Wave App received the highest overall score and the highest individual scores for engagement and aesthetics dimensions.

“We were unaware that Oncologists were studying our Artificial Intelligence Technology; and we’re delighted that the value and utility of Wave App was recognized by the team at Cedars-Sinai Medical Center,” says Matt Lashey, creator of Wave App and CEO of parent company, Treatment Technologies & Insights (TTI, Inc.). “The COVID-19 pandemic has introduced significant challenges in ensuring oncology patients understand their symptoms and receive the best possible care. We take great pride in empowering patients to take an active role in their treatment and to effectively communicate with their care teams, especially in a remote world.”

Wave App’s technology offers a holistic, real-time record & analysis of patient experiences, designed to engage patients in managing treatment side effects, provide doctors with better information for more confident decision-making, and ultimately improve protocols that lead to better outcomes in the future.

Wave App is an application from Treatment Technologies & Insights (TTI), a digital health company that creates patient-centered mobile apps, along with building physician portals and research databases. Tapping into the power of patient reported outcomes (PROs), TTI’s technology is focused on capturing and operationalizing PROs to impact healthcare.

TTI entered the PRO space in 2017 through their launch of chemoWave, a free health app for cancer patients with the same insights and tracking capabilities as Wave App. chemoWave is also available across all iPhone or Android mobile platforms.

Read more about the personal story that led to the creation of chemoWave in the American Journal of Managed Care.

Download Wave App FREE for Android here
Download Wave App FREE for Apple iOS here
Follow us on Facebook and Twitter.

SOURCE Treatment Technologies & Insights, Inc